CII
BSX icon

Capital International Inc’s Boston Scientific BSX Stock Holding History

Capital International Inc’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.1M Sell
119,400
-17,450
-13% -$948K 0.04% 237
2026
Q1 		$8.59M Sell
136,850
-85,077
-38% -$6.81M 0.07% 202
2025
Q4 		$21.2M Buy
221,927
+30,194
+16% +$2.96M 0.17% 148
2025
Q3 		$18.7M Buy
191,733
+10,718
+6% +$1.11M 0.15% 155
2025
Q2 		$19.4M Buy
181,015
+12,304
+7% +$1.24M 0.19% 145
2025
Q1 		$17M Buy
168,711
+20,652
+14% +$2.08M 0.21% 130
2024
Q4 		$13.2M Buy
148,059
+97,550
+193% +$8.59M 0.16% 149
2024
Q3 		$4.23M Buy
50,509
+15,463
+44% +$1.22M 0.05% 221
2024
Q2 		$2.7M Buy
35,046
+3,561
+11% +$261K 0.04% 240
2024
Q1 		$2.16M Buy
+31,485
New +$2.02M 0.03% 254
2021
Q1 		– Sell
-81,979
Closed -$2.95M – 296
2020
Q4 		$2.95M Sell
81,979
-459,765
-85% -$16.6M 0.03% 227
2020
Q3 		$20.7M Sell
541,744
-64,963
-11% -$2.5M 0.23% 115
2020
Q2 		$21.3M Buy
606,707
+220,473
+57% +$7.94M 0.26% 114
2020
Q1 		$12.6M Buy
386,234
+115,520
+43% +$4.51M 0.21% 105
2019
Q4 		$12.2M Buy
270,714
+1,281
+0.5% +$53.6K 0.17% 112
2019
Q3 		$11M Sell
269,433
-114,191
-30% -$4.84M 0.17% 116
2019
Q2 		$16.5M Buy
383,624
+312,485
+439% +$12M 1.15% 23
2019
Q1 		$2.73M Hold
71,139
– – 0.32% 70
2018
Q4 		$2.51M Buy
71,139
+3,963
+6% +$144K 0.34% 66
2018
Q3 		$2.59M Buy
+67,176
New +$2.35M 0.34% 71

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Inc's BSX Position: Q2 2026 in Review

Capital International Inc reduced its Boston Scientific (BSX) stake by 13% in Q2 2026, selling an estimated $948K and leaving 119,400 shares worth $5.1M. The position accounts for 0.04% of the portfolio, ranked #237.

Capital International Inc first reported a position in BSX in Q3 2018 and has held it in 20 quarters since. The position peaked at $21.3M in Q2 2020. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Capital International Inc held 119,400 shares of Boston Scientific worth $5.1M as of Q2 2026.
  • Capital International Inc sold 17,450 Boston Scientific shares in Q2 2026, an estimated $948K.
  • Boston Scientific made up 0.04% of Capital International Inc's portfolio in Q2 2026, its #237 holding.
  • Capital International Inc first reported a position in Boston Scientific in Q3 2018 and has held it in 20 quarters since.
  • Capital International Inc's Boston Scientific position peaked at $21.3M in Q2 2020.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.